161 related articles for article (PubMed ID: 33450435)
1. Expression profile of intestinal stem cell and cancer stem cell markers in gastric cancers with submucosal invasion.
Kim HS; Song HJ; Kim HU; Jeong IH; Koh HM; Shin JH; Jang BG
Pathol Res Pract; 2021 Feb; 218():153336. PubMed ID: 33450435
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
Jang BG; Lee BL; Kim WH
Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
[TBL] [Abstract][Full Text] [Related]
3. The Intestinal Stem Cell Marker SMOC2 Is an Independent Prognostic Marker Associated With Better Survival in Gastric Cancer.
Hyun CL; Park SJ; Kim HS; Song HJ; Kim HU; Lee C; Lee DH; Maeng YH; Kim YS; Jang B
Anticancer Res; 2021 Jul; 41(7):3689-3698. PubMed ID: 34230168
[TBL] [Abstract][Full Text] [Related]
4. Distribution of LGR5+ cells and associated implications during the early stage of gastric tumorigenesis.
Jang BG; Lee BL; Kim WH
PLoS One; 2013; 8(12):e82390. PubMed ID: 24340024
[TBL] [Abstract][Full Text] [Related]
5. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer.
Wakamatsu Y; Sakamoto N; Oo HZ; Naito Y; Uraoka N; Anami K; Sentani K; Oue N; Yasui W
Pathol Int; 2012 Feb; 62(2):112-9. PubMed ID: 22243781
[TBL] [Abstract][Full Text] [Related]
6. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
7. Intestinal Stem Cell Markers in the Intestinal Metaplasia of Stomach and Barrett's Esophagus.
Jang BG; Lee BL; Kim WH
PLoS One; 2015; 10(5):e0127300. PubMed ID: 25996368
[TBL] [Abstract][Full Text] [Related]
8. RSPO2 enhances cell invasion and migration via the WNT/β-catenin pathway in human gastric cancer.
Zhang H; Han X; Wei B; Fang J; Hou X; Lan T; Wei H
J Cell Biochem; 2019 Apr; 120(4):5813-5824. PubMed ID: 30362605
[TBL] [Abstract][Full Text] [Related]
9. Expression of LGR5, FZD7, TROY, and MIST1 in Perioperatively Treated Gastric Carcinomas and Correlation with Therapy Response.
Freiin Grote A; Halske C; Behrens HM; Krüger S; Wilhelm F; Egberts JH; Röcken C
Dis Markers; 2019; 2019():8154926. PubMed ID: 31827644
[TBL] [Abstract][Full Text] [Related]
10. Leucine-rich repeat-containing G-protein-coupled receptor 5 is associated with invasion, metastasis, and could be a potential therapeutic target in human gastric cancer.
Xi HQ; Cai AZ; Wu XS; Cui JX; Shen WS; Bian SB; Wang N; Li JY; Lu CR; Song Z; Wei B; Chen L
Br J Cancer; 2014 Apr; 110(8):2011-20. PubMed ID: 24594994
[TBL] [Abstract][Full Text] [Related]
11. Novel Insights into Gastric Cancer: Methylation of R-spondins and Regulation of LGR5 by SP1.
Wilhelm F; Simon E; Böger C; Behrens HM; Krüger S; Röcken C
Mol Cancer Res; 2017 Jun; 15(6):776-785. PubMed ID: 28219935
[TBL] [Abstract][Full Text] [Related]
12. Expression and functional regulation of stemness gene Lgr5 in esophageal squamous cell carcinoma.
Lv Z; Yu JJ; Zhang WJ; Xiong L; Wang F; Li LF; Zhou XL; Gao XY; Ding XF; Han L; Cai YF; Ma W; Wang LX
Oncotarget; 2017 Apr; 8(16):26492-26504. PubMed ID: 28404917
[TBL] [Abstract][Full Text] [Related]
13. EphB2 isolates a human marrow stromal cell subpopulation with enhanced ability to contribute to the resident intestinal cellular pool.
Colletti E; El Shabrawy D; Soland M; Yamagami T; Mokhtari S; Osborne C; Schlauch K; Zanjani ED; Porada CD; Almeida-Porada G
FASEB J; 2013 Jun; 27(6):2111-21. PubMed ID: 23413357
[TBL] [Abstract][Full Text] [Related]
14. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
[TBL] [Abstract][Full Text] [Related]
15. SMOC2, an intestinal stem cell marker, is an independent prognostic marker associated with better survival in colorectal cancers.
Jang BG; Kim HS; Bae JM; Kim WH; Kim HU; Kang GH
Sci Rep; 2020 Sep; 10(1):14591. PubMed ID: 32884102
[TBL] [Abstract][Full Text] [Related]
16. The spatial distribution of LGR5+ cells correlates with gastric cancer progression.
Simon E; Petke D; Böger C; Behrens HM; Warneke V; Ebert M; Röcken C
PLoS One; 2012; 7(4):e35486. PubMed ID: 22530031
[TBL] [Abstract][Full Text] [Related]
17. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
18. R-spondin 2-LGR4 system regulates growth, migration and invasion, epithelial-mesenchymal transition and stem-like properties of tongue squamous cell carcinoma via Wnt/β-catenin signaling.
Zhang L; Song Y; Ling Z; Li Y; Ren X; Yang J; Wang Z; Xia J; Zhang W; Cheng B
EBioMedicine; 2019 Jun; 44():275-288. PubMed ID: 31097406
[TBL] [Abstract][Full Text] [Related]
19. Interaction between the EPHB2 receptor and EFNB1 ligand drives gastric cancer invasion and metastasis via the Wnt/β-catenin/FAK pathway.
Hu Y; Xie Q; Zhao J; Yang R; Qin J; Li H; Zhao Y; Du X; Shi C
Int J Biol Macromol; 2024 Feb; 258(Pt 1):128848. PubMed ID: 38114003
[TBL] [Abstract][Full Text] [Related]
20. Lgr5 expression as stem cell marker in human gastric gland and its relatedness with other putative cancer stem cell markers.
Wu C; Xie Y; Gao F; Wang Y; Guo Y; Tian H; Li Y; Fan W
Gene; 2013 Aug; 525(1):18-25. PubMed ID: 23664892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
